Chiron Corp. received news early Tuesday that, when boiled down, meant it would not be a player in the 2004-2005 influenza market. That news not only dropped the company's stock by nearly 17 percent, it sent a shudder through a U.S. population already skittish about the flu. (BioWorld Today) Read More